We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
-0.2%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$60.8B
AUM Growth
+$1.76B
(+3%)
Cap. Flow
+$3.65B
Cap. Flow
% of AUM
6.01%
Top 10 Holdings %
Top 10 Hldgs %
23.06%
Holding
2,127
New
257
Increased
784
Reduced
545
Closed
271
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$353M |
| 2 |
AstraZeneca
AZN
|
+$299M |
| 3 |
RB Global
RBA
|
+$232M |
| 4 |
Apple
AAPL
|
+$225M |
| 5 |
American Tower
AMT
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$159M |
| 2 |
Goldman Sachs
GS
|
+$156M |
| 3 |
ASE Group
ASX
|
+$136M |
| 4 |
Merck
MRK
|
+$133M |
| 5 |
Baxter International
BAX
|
+$118M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.82% |
| 2 | Industrials | 13.22% |
| 3 | Financials | 11.81% |
| 4 | Healthcare | 9.89% |
| 5 | Consumer Discretionary | 7.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Globus Medical
GMED
$10.4B
| $9.78M | 0.02% |
113,479
+5,329
| +5% | +$478K |
|
427
BlackRock Enhanced Global Dividend Trust
BOE
$662M
| $9.72M | 0.02% |
886,755
-1,631
| -0.2% | -$19K |
|
428
Nucor
NUE
$56.4B
| $9.7M | 0.02% |
57,373
+3,705
| +7% | +$646K |
|
429
Elevance Health
ELV
$81.9B
| $9.7M | 0.02% |
33,119
-629
| -2% | -$207K |
|
430
Pfizer
PFE
$140B
| $9.55M | 0.02% |
340,255
-1,500,673
| -82% | -$40M |
|
431
Encompass Health
EHC
$11.2B
| $9.55M | 0.02% |
98,693
+25,335
| +35% | +$2.6M |
|
432
Assurant
AIZ
$13.7B
| $9.54M | 0.02% |
43,809
+24,815
| +131% | +$5.66M |
|
433
Quest Diagnostics
DGX
$25.1B
| $9.52M | 0.02% |
48,586
-27,248
| -36% | -$5.29M |
|
434
Viavi Solutions
VIAV
$9.75B
| $9.17M | 0.02% |
275,492
-34,609
| -11% | -$915K |
|
435
Vulcan Materials
VMC
$36.3B
| $9.16M | 0.02% |
33,632
+1,739
| +5% | +$512K |
|
436
EnerSys
ENS
$6.95B
| $9.14M | 0.02% |
52,599
-13,154
| -20% | -$2.23M |
|
437
Roku
ROKU
$21.1B
| $9.1M | 0.02% |
96,204
+23,092
| +32% | +$2.25M |
|
438
Dynatrace
DT
$12.1B
| $8.96M | 0.01% |
242,418
+120,426
| +99% | +$4.6M |
|
439
BlackRock Health Sciences Trust II
BMEZ
$957M
| $8.93M | 0.01% |
621,604
+243,054
| +64% | +$3.61M |
|
440
CME Group
CME
$92.2B
| $8.84M | 0.01% |
29,928
-15,448
| -34% | -$4.59M |
|
441
SPS Commerce
SPSC
$2.25B
| $8.82M | 0.01% |
158,384
-50,315
| -24% | -$3.63M |
|
442
Bank of N.T. Butterfield & Son
NTB
$2.42B
| $8.77M | 0.01% |
167,051
+94,596
| +131% | +$4.86M |
|
443
Rambus
RMBS
$10.4B
| $8.75M | 0.01% |
101,701
-196,169
| -66% | -$19.6M |
|
444
Seneca Foods Class A
SENEA
$1.13B
| $8.68M | 0.01% |
57,470
+13,564
| +31% | +$1.75M |
|
445
Regal Rexnord
RRX
$14.2B
| $8.68M | 0.01% |
46,331
-6,374
| -12% | -$1.18M |
|
446
RH
RH
$3.3B
| $8.62M | 0.01% |
61,641
-22,108
| -26% | -$4.03M |
|
447
Intercorp Financial Services
IFS
$6.63B
| $8.6M | 0.01% |
171,339
+5,328
| +3% | +$253K |
|
448
Gates Industrial Corporation Ltd.
GTES
$6.81B
| $8.51M | 0.01% |
376,264
+94,746
| +34% | +$2.3M |
|
|
SF
449
Stifel
SF
$12.3B
| $8.5M | 0.01% |
115,003
-9,419
| -8% | -$748K |
|
450
Nordson
NDSN
$16.5B
| $8.27M | 0.01% |
31,100
-125,544
| -80% | -$34.6M |
|
Similar funds
QCM
Lazard Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, Lazard Asset Management held 2,127 positions worth $60.8B, up 3% from $59B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Lazard Asset Management deployed $3.65B of net new capital in Q1 2026, opening 257 new positions and adding to 784 existing holdings. Its largest new stake was RB Global: 2,191,875 shares worth $210M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Micron Technology, an estimated $159M trimmed.
- Lazard Asset Management's largest Q1 2026 buy was RB Global: 2,191,875 shares worth $210M.
- Lazard Asset Management added most to NVIDIA in Q1 2026, an estimated $353M increase.
- Lazard Asset Management's biggest Q1 2026 reduction was Micron Technology, cutting an estimated $159M.
- Lazard Asset Management fully exited Baxter International in Q1 2026, selling an estimated $118M.
- Lazard Asset Management's ten largest holdings make up 23% of its $60.8B portfolio in Q1 2026.
- Lazard Asset Management opened 257 new positions and closed 271 in Q1 2026.
- Lazard Asset Management's portfolio value rose 3% quarter-over-quarter to $60.8B.
Based on Lazard Asset Management's 13F filing for Q1 2026, filed 15 May 2026.